Molina Healthcare, Inc. (MOH)
USD 323.82
(-2.58%)
USD 323.82
(-2.58%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 1.57 Billion USD | 34.1% |
| 2022 | 1.17 Billion USD | 15.0% |
| 2021 | 1.02 Billion USD | -5.38% |
| 2020 | 1.07 Billion USD | 3.26% |
| 2019 | 1.04 Billion USD | -7.69% |
| 2018 | 1.13 Billion USD | 303.78% |
| 2017 | -555 Million USD | -333.19% |
| 2016 | 238 Million USD | -38.5% |
| 2015 | 387 Million USD | 100.6% |
| 2014 | 192.91 Million USD | 41.27% |
| 2013 | 136.56 Million USD | 284.97% |
| 2012 | 35.47 Million USD | -55.75% |
| 2011 | 80.17 Million USD | -23.65% |
| 2010 | 105 Million USD | 82.95% |
| 2009 | 57.39 Million USD | -49.03% |
| 2008 | 112.6 Million USD | 14.52% |
| 2007 | 98.32 Million USD | 29.7% |
| 2006 | 75.81 Million USD | 65.6% |
| 2005 | 45.78 Million USD | -47.72% |
| 2004 | 87.56 Million USD | 29.25% |
| 2003 | 67.74 Million USD | -94.25% |
| 2002 | 1.17 Billion USD | 2246.51% |
| 2001 | 50.21 Million USD | 107.18% |
| 2000 | 24.23 Million USD | 38.61% |
| 1999 | 17.48 Million USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | 426 Million USD | 34.81% |
| 2024 Q2 | 434 Million USD | 1.88% |
| 2024 Q3 | 467 Million USD | 7.6% |
| 2023 Q3 | 359 Million USD | -18.96% |
| 2023 Q4 | 316 Million USD | -11.98% |
| 2023 Q1 | 455 Million USD | 45.37% |
| 2023 Q2 | 443 Million USD | -2.64% |
| 2023 FY | 1.57 Billion USD | 34.1% |
| 2022 Q1 | 372 Million USD | 94.76% |
| 2022 Q3 | 335 Million USD | -7.2% |
| 2022 Q4 | 313 Million USD | -6.57% |
| 2022 FY | 1.17 Billion USD | 15.0% |
| 2022 Q2 | 361 Million USD | -2.96% |
| 2021 Q4 | 191 Million USD | -13.57% |
| 2021 Q1 | 335 Million USD | 268.13% |
| 2021 FY | 1.02 Billion USD | -5.38% |
| 2021 Q2 | 273 Million USD | -18.51% |
| 2021 Q3 | 221 Million USD | -19.05% |
| 2020 Q2 | 424 Million USD | 54.74% |
| 2020 FY | 1.07 Billion USD | 3.26% |
| 2020 Q1 | 274 Million USD | 13.22% |
| 2020 Q4 | 91 Million USD | -68.51% |
| 2020 Q3 | 289 Million USD | -31.84% |
| 2019 FY | 1.04 Billion USD | -7.69% |
| 2019 Q1 | 280 Million USD | 2.94% |
| 2019 Q2 | 265 Million USD | -5.36% |
| 2019 Q4 | 242 Million USD | -5.84% |
| 2019 Q3 | 257 Million USD | -3.02% |
| 2018 FY | 1.13 Billion USD | 303.78% |
| 2018 Q4 | 272 Million USD | -7.8% |
| 2018 Q2 | 342 Million USD | 54.05% |
| 2018 Q1 | 222 Million USD | 182.53% |
| 2018 Q3 | 295 Million USD | -13.74% |
| 2017 Q2 | -287 Million USD | -450.0% |
| 2017 Q1 | 82 Million USD | 210.81% |
| 2017 FY | -555 Million USD | -333.19% |
| 2017 Q3 | -81 Million USD | 71.78% |
| 2017 Q4 | -269 Million USD | -232.1% |
| 2016 Q1 | 89 Million USD | 17.11% |
| 2016 Q3 | 118 Million USD | 12.38% |
| 2016 Q4 | -74 Million USD | -162.71% |
| 2016 Q2 | 105 Million USD | 17.98% |
| 2016 FY | 238 Million USD | -38.5% |
| 2015 Q2 | 115.62 Million USD | 40.62% |
| 2015 Q4 | 76 Million USD | -32.66% |
| 2015 Q3 | 112.85 Million USD | -2.4% |
| 2015 Q1 | 82.23 Million USD | -14.74% |
| 2015 FY | 387 Million USD | 100.6% |
| 2014 FY | 192.91 Million USD | 41.27% |
| 2014 Q4 | 96.44 Million USD | 142.45% |
| 2014 Q3 | 39.77 Million USD | 22.67% |
| 2014 Q2 | 32.42 Million USD | 33.63% |
| 2014 Q1 | 24.26 Million USD | 1003.8% |
| 2013 Q4 | -2.68 Million USD | -110.77% |
| 2013 Q2 | 46.44 Million USD | -30.77% |
| 2013 Q3 | 24.92 Million USD | -46.33% |
| 2013 Q1 | 67.09 Million USD | 23.94% |
| 2013 FY | 136.56 Million USD | 284.97% |
| 2012 Q3 | 7.18 Million USD | 112.13% |
| 2012 Q4 | 54.13 Million USD | 653.21% |
| 2012 Q2 | -59.26 Million USD | -277.34% |
| 2012 Q1 | 33.42 Million USD | 307.54% |
| 2012 FY | 35.47 Million USD | -55.75% |
| 2011 Q2 | 31.41 Million USD | 0.35% |
| 2011 FY | 80.17 Million USD | -23.65% |
| 2011 Q4 | -16.1 Million USD | -147.97% |
| 2011 Q3 | 33.56 Million USD | 6.86% |
| 2011 Q1 | 31.3 Million USD | -6.38% |
| 2010 FY | 105 Million USD | 82.95% |
| 2010 Q2 | 21.17 Million USD | 3.62% |
| 2010 Q1 | 20.43 Million USD | 649.11% |
| 2010 Q3 | 29.95 Million USD | 41.43% |
| 2010 Q4 | 33.43 Million USD | 11.61% |
| 2009 FY | 57.39 Million USD | -49.03% |
| 2009 Q1 | 24.11 Million USD | -12.2% |
| 2009 Q2 | 20.72 Million USD | -14.05% |
| 2009 Q3 | 16.27 Million USD | -21.48% |
| 2009 Q4 | -3.72 Million USD | -122.87% |
| 2008 Q2 | 30.25 Million USD | 23.75% |
| 2008 Q1 | 24.45 Million USD | -20.18% |
| 2008 FY | 112.6 Million USD | 14.52% |
| 2008 Q4 | 27.46 Million USD | -9.73% |
| 2008 Q3 | 30.42 Million USD | 0.57% |
| 2007 FY | 98.32 Million USD | 29.7% |
| 2007 Q3 | 28.81 Million USD | 29.31% |
| 2007 Q2 | 22.28 Million USD | 34.28% |
| 2007 Q1 | 16.59 Million USD | -14.71% |
| 2007 Q4 | 30.63 Million USD | 6.31% |
| 2006 Q1 | 14.15 Million USD | -19.48% |
| 2006 Q3 | 20.45 Million USD | -5.9% |
| 2006 Q4 | 19.45 Million USD | -4.89% |
| 2006 FY | 75.81 Million USD | 65.6% |
| 2006 Q2 | 21.74 Million USD | 53.6% |
| 2005 FY | 45.78 Million USD | -47.72% |
| 2005 Q2 | -6.77 Million USD | -128.11% |
| 2005 Q1 | 24.09 Million USD | -8.35% |
| 2005 Q4 | 17.57 Million USD | 61.55% |
| 2005 Q3 | 10.88 Million USD | 260.65% |
| 2004 Q3 | 25.08 Million USD | 29.1% |
| 2004 Q4 | 26.28 Million USD | 4.78% |
| 2004 FY | 87.56 Million USD | 29.25% |
| 2004 Q2 | 19.43 Million USD | 16.01% |
| 2004 Q1 | 16.75 Million USD | -12.8% |
| 2003 Q1 | 356.2 Million USD | 0.0% |
| 2003 FY | 67.74 Million USD | -94.25% |
| 2003 Q4 | 19.21 Million USD | 9.2% |
| 2003 Q3 | 17.59 Million USD | -0.01% |
| 2003 Q2 | 17.59 Million USD | -95.06% |
| 2002 FY | 1.17 Billion USD | 2246.51% |
| 2001 FY | 50.21 Million USD | 107.18% |
| 2000 FY | 24.23 Million USD | 38.61% |
| 1999 FY | 17.48 Million USD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Cigna Corporation | 8.53 Billion USD | 81.572% |
| Centene Corporation | 2.93 Billion USD | 46.314% |
| CVS Health Corporation | 13.74 Billion USD | 88.554% |
| Elevance Health Inc. | 133.96 Billion USD | 98.826% |
| Humana Inc. | 4.01 Billion USD | 60.802% |
| Oscar Health, Inc. | -235.61 Million USD | 767.615% |
| UnitedHealth Group Incorporated | 32.35 Billion USD | 95.139% |